Expert Interview
A Second Look: Discussing results from the Phase 2, randomized, double-blind, placebo-controlled study of NTLA-2002 in patients with HAE
Ticker(s): NTLAInsititution: Allergy Partners / Allermi Medical Assoc
- clinical allergist with over 17 years of experience.
- maanges 4 pts with HAE
- treats both pediatric and adults
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
